antiretrovirals

PreclinicalSmall molecule

CCode Pharma

antiretrovirals is one of 55 small molecule programs targeting HIV infection. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

HIV InfectionActive, not recruiting

HIV InfectionPreclinical

Active, not recruiting

Competition

Competitive Landscape

123 competitors in HIV Infection

#DrugCompanyPhaseTrials

Zofran

Viread

Zometa

Agenerase

GGlaxo Dba Glaxosmithkline

Approved

4 5

Calciferol

Crestor

Istodax

Marinol

Neoral

Tybost

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

HIV infection3 trials

Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants

Recruiting·CCode Pharma·Phase 2·NCT06676410·40 enrolled

Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection

Completed·UUniversity of California, Los Angeles··NCT03205696·101 enrolled

Bone Mineral Density (BMD) in HIV Infection

Terminated·UUniversity Hospital, Strasbourg, France·N/A·NCT00146094·44 enrolled

Effectiveness1 trial

The Impact and Cost-effectiveness of Safer Conception Strategies for HIV-discordant Couples (SAFER)

Completed·UUniversity of California, San Francisco··NCT03049176·46 enrolled

Treatment1 trial

Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART

Completed·—·Phase 2·NCT03041012·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for antiretrovirals. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — antiretrovirals compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for antiretrovirals. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Code Pharma company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: CCode Pharma

antiretrovirals

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

HIV infection3 trials

Effectiveness1 trial

Treatment1 trial

References

Drug Info

Quick Facts

Related News